Novel petides as NS3-serine protease inhibitors of hepatitis C virus

The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorder...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JINPING L. MC CORMICK, SUSAN Y. TAMURA, YI-TSUNG LIU, RUSSEL E. PIKE, SCOTT JEFFREY KEMP, MARGUERITA LIM-WILBY, ASHOK ARASAPPAN, RAYMOND G. LOVEY, SRIKANTH VENKATRAMAN, KEVIN X. CHEN, HENRY A. VACCARO, TIN-YAU CHAN, ZHAONING ZHU, STEPHANE L. BOGEN, ODILE ESTHER LEVY, FRANK BENNETT, EDWIN E. JAO, HAIYAN WANG, TEJAL N. PAREKH, F. GEORGE NJOROGE, PATRICK A. PINTO, VIYYOR MOOPIL GIRIJAVALLABHAN, ANIL K. SAKSENA, BAMA SANTHANAM, ASHIT K. GANGULY
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.